MedTrace Logo

Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder

NCT00134446 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2005-10-31

No results posted yet for this study

Summary

The purpose of this study is to determine if transcranial magnetic stimulation at 1 HZ to the right frontal cortex will decrease the symptoms of post-traumatic stress disorder (PTSD).

Conditions

  • Post-Traumatic Stress Disorders

Interventions

DEVICE

transcranial magnetic stimulation

Sponsors & Collaborators

  • White River Junction Veterans Affairs Medical Center

    lead FED

Principal Investigators

  • Bradley V Watts, MD · White River Junction Veterans Affairs Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00134446 on ClinicalTrials.gov